<qa>  What is the ARM I:INDUCTION THERAPY?ARM I: INDUCTION THERAPY: Patients receive nivolumab intravenously IV over 60 minutes on day 1, ipilimumab IV over 90 minutes on day 1, and sargramostim subcutaneously SC on days 1-14. Treatment repeats every 21 days for 4 courses in the absence of disease progression or unacceptable toxicity. 